These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29114967)

  • 21. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE; Trent JT; Kerdel FA
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure.
    Bentley P; Rosso M; Sadnicka A; Israeli-Korn S; Laffan M; Sharma P
    J Clin Pharm Ther; 2012 Jun; 37(3):286-90. PubMed ID: 21767284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases.
    Prins C; Kerdel FA; Padilla RS; Hunziker T; Chimenti S; Viard I; Mauri DN; Flynn K; Trent J; Margolis DJ; Saurat JH; French LE;
    Arch Dermatol; 2003 Jan; 139(1):26-32. PubMed ID: 12533160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin-induced hemolytic anemia in a patient with juvenile dermatomyositis.
    Clemenz MR; McGowan Iv JW; Shuler MJ; Lynn AW
    J Drugs Dermatol; 2013 Jan; 12(1):111-3. PubMed ID: 23377338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience.
    Stella M; Cassano P; Bollero D; Clemente A; Giorio G
    Dermatology; 2001; 203(1):45-9. PubMed ID: 11549799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
    Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
    Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin and the kidney--a two-edged sword.
    Orbach H; Tishler M; Shoenfeld Y
    Semin Arthritis Rheum; 2004 Dec; 34(3):593-601. PubMed ID: 15609263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.
    Enk AH; Hadaschik EN; Eming R; Fierlbeck G; French LE; Girolomoni G; Hertl M; Jolles S; Karpati S; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1657-1669. PubMed ID: 27406069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-SSA antibodies are present in immunoglobulin preparations.
    van der Molen RG; Hamann D; Jacobs JF; van der Meer A; de Jong J; Kramer C; Strengers PF; van der Meer JW
    Transfusion; 2015 Apr; 55(4):832-7. PubMed ID: 25394209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study.
    Prins C; Vittorio C; Padilla RS; Hunziker T; Itin P; Förster J; Bröcker EB; Saurat JH; French LE
    Dermatology; 2003; 207(1):96-9. PubMed ID: 12835566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Khalili B; Bahna SL
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
    Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
    J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin therapy for children with Stevens-Johnson syndrome.
    Morici MV; Galen WK; Shetty AK; Lebouef RP; Gouri TP; Cowan GS; Gedalia A
    J Rheumatol; 2000 Oct; 27(10):2494-7. PubMed ID: 11036849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
    Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA
    Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IVIG for the treatment of toxic epidermal necrolysis.
    Mittmann N; Chan BC; Knowles S; Shear NH
    Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutropenia as a complication of high-dose intravenous immunoglobulin therapy in adult patients with neuroimmunologic disorders.
    Matsuda M; Hosoda W; Sekijima Y; Hoshi K; Hashimoto T; Itoh S; Ikeda S
    Clin Neuropharmacol; 2003; 26(6):306-11. PubMed ID: 14646610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.
    Lukan N; Lazurova I; Racz O; Kristofova B; Tkac I
    Bratisl Lek Listy; 2008; 109(11):489-92. PubMed ID: 19205557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.
    Hartung HP; Mouthon L; Ahmed R; Jordan S; Laupland KB; Jolles S
    Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):23-33. PubMed ID: 19883421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Don't neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia.
    Ucar İ; Koyuncu MB; Solmaz AA; Ugurludogan AC; Mercan S; Kucuk M; Unal T; Mazman S; Atilla E
    Transfus Clin Biol; 2023 Feb; 30(1):11-15. PubMed ID: 36028153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality.
    Aires DJ; Fraga G; Korentager R; Richie CP; Aggarwal S; Wick J; Liu DY
    J Drugs Dermatol; 2013 Jun; 12(6):679-84. PubMed ID: 23839186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.